Concepedia

Author

Junichi Kamata

Eisai (Japan)

Also Known As

JUNICHI KAMATA, Jun-ichi Kamata, Junichi Kamata

8

Publications

675

Citations

6

H-Index

27

Concepts

All Affiliations

Eisai (Japan)
JK

About

Junichi Kamata is an author at Eisai (Japan) specializing in medicine, radiation oncology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

177

2

Cell Biology

2

2

112

3

Natural Sciences

1

1

39

4

Biochemistry

1

1

39

5

Cellular Physiology

1

1

102

Junichi Kamata

×

6

Publications

671

Citations

6

H-Index

YearCitations

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

Yuji Yamamoto, Junji Matsui, Tomohiro Matsushima,

Vascular Cell

2014

478

Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.

Yasuhiro Funahashi, Naoko Hata Sugi, Taro Semba,

PubMed

2002

102

Synthesis and Evaluation of Novel Pyrimido-Acridone, -Phenoxadine, and -Carbazole as Topoisomerase II Inhibitors

Junichi Kamata, Toshimi Okada, Yoshihiko Kotake,

Chemical and Pharmaceutical Bulletin

2004

39

Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.

Katsuji Nakamura, Hiroyuki Sugumi, Atsumi Yamaguchi,

PubMed

2002

26

A novel carbazole topoisomerase II poison, ER‐37328: potent tumoricidal activity against human solid tumors <i>in vitro</i> and <i>in vivo</i>

Katsuji Nakamura, Toshimitsu Uenaka, Takeshi Nagasu,

Cancer Science

2003

16

Microregional antitumor activity of a small-molecule hypoxia-inducible factor 1 inhibitor

Kiyoshi Okamoto, Daisuke Ito, Kazuki Miyazaki,

International Journal of Molecular Medicine

2011

10

Page 1